Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Mkt Cap
Market Capitalization
₹729Cr
Rev Gr TTM
Revenue Growth TTM
56.95%
OSEL Devices Ltd is an Indian electronics manufacturer that has transformed itself from a niche LED display maker into a multi-vertical enterprise spanning medical devices and brand-licensed mobile phones - all under one roof. Incorporated in 2006 and listed on the NSE Emerge SME platform, the company designs, builds and sells its own products across three distinct lines, operating from a manufacturing base in Greater Noida, Uttar Pradesh. The recurring pattern is vertical integration: OSEL consistently moves from making hardware to capturing the full value chain - adding proprietary software, owning the retail endpoint, or securing the brand licence - so that each business earns more than a simple manufacturing margin.
# Business segments
Three businesses at different stages - a display-hardware engine with a software layer, a hearing-aid operation that reaches all the way to the patient, and a newly launched mobile-phone brand - each built by extending from manufacturing into the adjacent value that competitors leave on the table.
## 1. LED displays: the original engine with a software moat
**OSEL makes and installs LED screens for enterprises and government, but the recurring revenue from its own cloud-based content-management platform is what sets it apart from hardware-only rivals.**
- **Design-to-after-sales under one roof** - the business handles everything from in-house SMT (surface-mount technology) manufacturing and panel vetting to installation and after-sales support across India, which cuts the bill of materials by 4-6% versus peers and delivers installations in 7-30 days against an industry norm of 45 days.
- **Software that hardware competitors cannot match** - its proprietary Digital Signage CMS (content-management system) is a cloud platform that lets customers manage and distribute content across screens in multiple locations; it is hardware-agnostic, already live at more than 300 locations, and generates ₹700-800 per display per month, creating stickiness that pure hardware players cannot replicate.
- **Leasing turns a one-time sale into a decade-long relationship** - through the subsidiary Proxima Leasing, OSEL offers screens on an OPEX (operating-expenditure) model where the hardware cost is recovered in roughly two years and the remaining seven to eight years of product life generate residual income, converting capital purchases into recurring lease revenue.
- **A China-plus-one manufacturing bet** - the company is setting up a facility at JNPA SEZ (a special economic zone near Mumbai's port) to manufacture LED displays with duty-free imports and lower logistics costs, positioning itself as an alternative to Chinese suppliers who face higher customs duties when exporting to India.
- **Clients that signal reliability** - installations have been delivered for DRDO, ISRO, Doordarshan, IIT Roorkee, PVR, Adidas and the Golden Temple, spanning government, broadcasting, education, retail and religious sites, which demonstrates the breadth of use cases the product line serves.
## 2. Hearing aids: the full-stack medical-device play
**OSEL does not just manufacture hearing aids - it holds US FDA registration, supplies government tenders, makes devices for other brands, and now owns the clinics that dispense them to patients, capturing margin at every step from factory to ear.**
- **Certifications that act as a barrier to entry** - the Greater Noida facility holds US FDA registration, ISO 13485 (the global medical-device quality standard), CDSCO MD-5 certification for high-precision devices, ZED Gold manufacturing credentials, and BIS licences - a combination the company describes as "licences that take competitors difficult to cross".
- **Four sales channels, one device** - the same hearing aid sells through government tenders under the ADIP scheme (earning ₹2,000-5,000 per unit), through private clinics (at a significantly higher net margin), as white-label product for other brands, and as exports to the Middle East, Africa and the US, spreading risk across unrelated buyer types.
- **Owning the clinic, not just the device** - through the step-down subsidiary SFL Hearing Solutions, OSEL now operates roughly 40-41 multi-brand audiology clinics staffed by in-house audiologists, capturing the retail margin that would otherwise go to a third-party dispenser.
- **An audiologist advantage in a severely underserved market** - India has roughly one audiologist for every 500,000 people against a global best-practice of one per 10,000, so employing audiologists inside SFL clinics gives OSEL a distribution and trust advantage that pure manufacturers lack.
- **R&D and testing infrastructure being built with government backing** - the company received in-principle approval from the Department of Pharmaceuticals for a hearing-aid testing facility under a government scheme, with a grant covering up to half the project cost, and has appointed a Chief Product Officer with over 38 years in audiology to lead product development toward higher-end features.
## 3. Philips mobile phones: a brand licence aimed at the mass market
**OSEL is the exclusive India brand licensee for Philips feature phones, smartphones and tablets, manufacturing under Make in India and selling through a network of more than 13,800 retail touchpoints to occupy the space between premium international brands and Chinese competitors.**
- **A brand gap in the accessible price band** - the strategic logic rests on the observation that India's mass-market smartphone segment has "no established multinational name" in the accessible price band outside Samsung and Apple, so the Philips brand is positioned to offer an international name at a price point where Chinese brands currently dominate.
- **Phased rollout from feature phones to tablets** - Phase 1 launched feature phones in 2025 with models carrying Type-C charging and digital cameras; Phase 2 brought 5G smartphones in December 2025 with up to 8 GB RAM and 256 GB storage; Phase 3 is expected to introduce tablets by December 2026, building the portfolio step by step.
- **Distribution built at speed** - the go-to-market infrastructure already includes 268 distributors, over 13,800 retail touchpoints and 569 service centres across India, and the business sold 4.55 lakh units in the second half of FY26 alone, showing rapid retail uptake.
- **One of only two international brands in India's feature-phone market** - the feature-phone segment moves 50-55 lakh units a month and is worth roughly ₹9,000-10,000 crore annually; Philips is the only international brand besides Nokia competing there, and customers are willing to pay a small premium for the brand name.
# Group structure and partners
**OSEL Devices is the listed parent, and it has built a ring of wholly owned subsidiaries - each with a distinct job: leasing screens, running hearing-aid clinics, and developing an export-oriented manufacturing zone - while relying on a handful of strategic brand and distribution partners.**
- **OSEL Healthcare and SFL Hearing Solutions** - OSEL Healthcare was incorporated in February 2026 as a wholly owned subsidiary, and in March 2026 it acquired 90.69% of SFL Hearing Solutions for ₹30 crore, making SFL a step-down subsidiary that operates the chain of audiology clinics serving as OSEL's retail leg for hearing aids.
- **Proxima Leasing** - incorporated in December 2025 as a wholly owned subsidiary to handle the leasing and renting of LED displays, converting one-time hardware purchases into recurring OPEX contracts for customers.
- **OSEL Industrial Park** - a wholly owned subsidiary that received a Letter of Intent for Co-Developer status on a 5.01-acre plot at JNPA SEZ, Navi Mumbai, where it will build an export-oriented manufacturing hub with SEZ tax benefits and port logistics advantages, with commercialisation expected from April 2027.
- **TPV Audio and Visual Technology** - the entity authorised by Koninklijke Philips N.V. that granted OSEL the Strategic Cooperation Agreement to manufacture and distribute Philips-branded mobile phones, tablets and other items in India, making OSEL the brand custodian for Philips Mobiles in the country.
- **Frye Electronics and Earkart** - Frye Electronics of Oregon, USA, appointed OSEL as distributor for its Hearing Aid Analyzer with exclusive rights in the Indian Subcontinent, while Earkart Private Limited was appointed as the exclusive retail distributor for OSEL's hearing aids within India for an initial two-year term.
Documents — OSEL Devices Ltd
- Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/mtpzd4f22ar80v7glhq8avjv.pdf
- Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/phc5zy1t771y9jdtn0znpqrx.pdf
- Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/l3x1754kce0eye7g8nlk38np.pdf
- Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/f3zt3d7x49vxeqj2n6rgdnxg.pdf
- Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/3h18gnf03ubx304spgkgtict.pdf
- Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/prdo2qd5xklzkyvt8d9r5w0p.pdf
- Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/u3ina8ouger9tsbhj7mzxuvb.pdf
- Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/xdgo8rsneuoyj3e0djqigiok.pdf
- Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/0ewi1hlkdbnnjthvg6iy2hb7.pdf
- Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/9y1ighjtvun3wku0xkqo1uzv.pdf
- Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/hp170nkfe7d3hoa0zujhqc5r.pdf
- FY2025 Annual Report (PDF): https://www.stockscans.in/document/uk84fis0cijekw3lfgzdkz1p.pdf
Concall Transcript Summaries — OSEL Devices Ltd
- Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AOSELDEVICE/transcript-notes/202603/mtpzd4f22ar80v7glhq8avjv.pdf
- Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AOSELDEVICE/transcript-notes/202509/phc5zy1t771y9jdtn0znpqrx.pdf
- Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AOSELDEVICE/transcript-notes/202503/l3x1754kce0eye7g8nlk38np.pdf